About Conference
Asian Symposium on Advancement in Hematology and Oncology promotes scientific exchange, clinical excellence, and innovations in cancer care.
Highlights
Expert presentations, breakthrough research, hematologic malignancy updates, oncology advancements, case discussions, networking, and collaborative learning opportunities. This promotes scientific exchange, and innovations in cancer care.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
New First-Line Option for Advanced ALK-Positive Lung Cancer
2.
An ultrasound breast patch with conformability might help with early breast cancer detection.
3.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
4.
Team finds broken 'brake' on cancer mutation machine.
5.
ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death
1.
Community-Based Cancer Survivorship Support Systems
2.
Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells
3.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
4.
Unmasking the Hidden Symptoms of Ovarian Cancer
5.
Transformative Frameworks in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
Recommended News For You
1.
Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.
2.
C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.
3.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
4.
Decoding calcifications in breast cancer: Towards personalized medicine
5.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
Conferences That Might Interest You
Recommended Articles For You
1.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
2.
Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment
3.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
4.
Uncovering the Mystery of the Sessile Serrated Adenoma
5.
A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51%
Boost Your Knowledge With These Quizzes
1.
Quiz on Tumor Markers in Testicular Cancer: Key Tools for Monitoring and Management
2.
Quiz on Asciminib in High-Risk CML: A Game Changer in Targeted Therapy
3.
Quiz on Radiation Therapy for Brain Tumors: Are You on Target with the Basics?
4.
Quiz on Indications for Urological Intervention in Kidney Stones: What Clinical Factors Determine the Need for Surgical Management in Patients Presenting with Urolithiasis?
5.
Quiz on Epigenetic Skin Care
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge